Zobrazeno 1 - 10
of 113
pro vyhledávání: '"A.M. Brunt"'
Autor:
P. Hall, S. Howell, R. Venkitaraman, A. Thomson, F. Raja, J. King, C. Michie, S. Khan, A.M. Brunt, D. Gahir, K. McAdam, J. Cooner, N. Kane
Publikováno v:
Breast, Vol 68, Iss , Pp S47- (2023)
Externí odkaz:
https://doaj.org/article/489ccd2539a74adfa763a4619d25e655
Autor:
I.N. Fernando, S. Lax, S.J. Bowden, I. Ahmed, J.H. Steven, M. Churn, A.M. Brunt, R.K. Agrawal, P. Canney, A. Stevens, D.W. Rea
Publikováno v:
Clinical Oncology. 35:397-407
Publikováno v:
Clinical Oncology. 34:332-339
There is a sound empirical basis for hypofractionation in radiotherapy for breast cancer. This article reviews the radiobiological implications of hypofractionation in breast cancer derived from a series of clinical trials that began when 50 Gy in 25
Autor:
J.R. Yarnold, A.M. Brunt, Navita Somaiah, Joanne S Haviland, Judith M Bliss, Duncan Wheatley, Anna M. Kirby
Publikováno v:
Clinical Oncology. 33:430-439
Introduction The phase 3 FAST-Forward trial reported outcomes for 26 and 27 Gy schedules delivered in 5 fractions over 1 week versus 40 Gy in 15 fractions over 3 weeks in 4000 patients. We discuss concerns raised by the radiotherapy community in rela
Autor:
Myria Nikolaou, Timothy J. Perren, Gia Nemsadze, Richard D. Baird, Robert McEwen, Daniel Stetson, Duncan Wheatley, A.M. Brunt, Hayley Cartwright, Max McLaughlin-Callan, Jean-Marc Ferrero, Peter Schmid, Cheryl Lawrence, Jacinta Abraham, Nicholas C. Turner, László Mangel, Melissa Phillips, Matthew Burgess, Peter Hall, John Conibear, Andrew Foxley, Aaron Prendergast, Kelly Mousa, Robert Stein, Yeon Hee Park, Javier Cortes, Stephen Chan, Elza C. de Bruin, Brian Dougherty
Publikováno v:
Cancer Research. 81:PD1-11
Background: In the PAKT study, addition of the oral AKT inhibitor capivasertib to 1st-line paclitaxel therapy for metastatic TNBC resulted in significantly longer progression-free survival (PFS; primary endpoint; Schmid, J Clin Oncol 2020). The strat
Autor:
David J. Eaton, John Yarnold, I.S. Bhattacharya, A.M. Brunt, S. Lightowlers, E. Sawyer, Jennifer Titley, C. Coles, C. Chan, Ellen M. Donovan, Isabel Syndikus, L. Stones, Anna M. Kirby, M.L. Jefford, C. Rajapakse, Joanne S Haviland, N. Twyman, Y. Tsang, Penelope Hopwood, Judith M Bliss, Clare Griffin
Publikováno v:
Radiotherapy and Oncology. 161:S197-S199
Autor:
Martin S. Hogg, Jean Tremlett, John Yarnold, Duncan Wheatley, K Venables, Ellen M. Donovan, Helen Passant, Peter Bliss, Joanna Bowen, Peter Barrett-Lee, Sri Kumar, Hafiz Algurafi, Joanne S Haviland, Adrian Harnett, D. Bloomfield, Y. Tsang, Abdulla Alhasso, Liz Sherwin, M. Sydenham, Judith M Bliss, R.K. Agrawal, Andy Goodman, Mary Quigley, A.M. Brunt, Isabel Syndikus, Alan L Stewart
Publikováno v:
Journal of Clinical Oncology. 38:3261-3272
PURPOSE Previous studies of hypofractionated adjuvant whole-breast radiotherapy for early breast cancer established a 15- or 16-fraction (fr) regimen as standard. The FAST Trial (CRUKE/04/015) evaluated normal tissue effects (NTE) and disease outcome
Autor:
D. Wheatley, J. Haviland, J. Patel, M. Sydenham, A. Alhasso, C. Chan, S. Cleator, C. Coles, E. Donovan, A. Kirby, C. Kirwan, Z. Nabi, E. Sawyer, N. Somaiah, I. Syndikus, K. Venables, J. Yarnold, A.M. Brunt, J. Bliss
Publikováno v:
Radiotherapy and Oncology. 170:S75-S76
Autor:
Anna M. Kirby, Sanjoy Chatterjee, B. Offersen, O. Kaidar Person, Liesbeth J. Boersma, Philip Poortmans, Sofia Rivera, Gerard G Hanna, A.M. Brunt, Icro Meattini, Charlotte E. Coles, Ángel Montero Luis, Ingvil Mjaaland, Judith M Bliss, Reshma Jagsi, Gustavo Nader Marta, Cynthia Aristei
Publikováno v:
Clinical Oncology
Clinical oncology, 32(5), 279-281. Elsevier Science
Clinical Oncology (Royal College of Radiologists (Great Britain)
Coles, C E, Aristei, C, Bliss, J, Boersma, L, Brunt, A M, Chatterjee, S, Hanna, G, Jagsi, R, Kaidar Person, O, Kirby, A, Mjaaland, I, Meattini, I, Luis, A M, Marta, G N, Offersen, B, Poortmans, P & Rivera, S 2020, ' International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic ', Clinical Oncology, vol. 32, no. 5, pp. 279-281 . https://doi.org/10.1016/j.clon.2020.03.006
Clinical oncology, 32(5), 279-281. Elsevier Science
Clinical Oncology (Royal College of Radiologists (Great Britain)
Coles, C E, Aristei, C, Bliss, J, Boersma, L, Brunt, A M, Chatterjee, S, Hanna, G, Jagsi, R, Kaidar Person, O, Kirby, A, Mjaaland, I, Meattini, I, Luis, A M, Marta, G N, Offersen, B, Poortmans, P & Rivera, S 2020, ' International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic ', Clinical Oncology, vol. 32, no. 5, pp. 279-281 . https://doi.org/10.1016/j.clon.2020.03.006
'No abstract'
Autor:
A.M. Brunt, Elizabeth A. Mittendorf, Michelle E. Melisko, Igor Bondarenko, Grybach Sergii, Julie A. Price Hiller, George E. Peoples, Biao Lu, Katarina Petrakova
Publikováno v:
Clinical Cancer Research. 25:4248-4254
Purpose: In phase I/II studies, nelipepimut-S (NP-S) plus GM-CSF vaccine was well tolerated and effectively raised HER2-specific immunity in patients with breast cancer. Results from a prespecified interim analysis of a phase III trial assessing NP-S